Estrogen defi ciency and low-calcium diet increased bone loss and urinary calcium excretion but did not alter arterial stiffness in young female rats Abstract Many epidemiological studies have reported that the severity of arterial diseases such as arterial calcifi cation and stiffness is inversely related to bone loss, i.e., osteoporosis. However, the nature of this relationship is unclear. The purpose of the present study was to examine the infl uences of estrogen defi ciency and/or low-calcium diet (0.1% Ca) on bone metabolism and calcium balance, as well as aortic wall composition and stiffness in young female rats. Twenty-eight 6-week-old female rats were randomized into four groups: OVX-Low calcium (OL) and OVX-Normal calcium groups (ON) were ovariectomized, and Sham-Low calcium (SL) and Sham-Normal calcium groups (SN) were sham-operated. After 12 weeks, the bone mineral density of the lumbar spine and tibial proximal metaphysis were signifi cantly lower in ON than in SN, and also signifi cantly lower in OL than in ON. Additionally, OL rats had significant higher (vs. SN and SL) urinary deoxypyridinoline, but not urinary calcium, excretion at 4 weeks after ovariectomy. However, at 12 weeks after ovariectomy, urinary calcium excretion was signifi cantly higher in OL than in SL, with corresponding increases in two bone turnover markers, bone-type alkaline phosphatase and tartrate-resistant acid phosphatase. Neither estrogen defi ciency nor low-calcium diet affected aortic stiffness or elastin degeneration and calcium deposition over the course of the present study, although changes of bone metabolism occurred rapidly. Taken together, these results show that bone loss and arterial stiffness did not progress simultaneously in the present experimental protocol.
Introduction
A rapid demographic shift toward aging societies has resulted in the increased prevalence of age-related diseases such as osteoporosis and cardiovascular disease, in addition to morbidity and disability in elderly patients. Such chronic diseases have increased healthcare costs not only in Japan but also in other developed countries [1] [2] [3] [4] .
The most common type of osteoporosis is the postmenopausal bone loss associated with ovarian hormone deficiency and dietary low calcium intake [5] [6] [7] . Rapid bone loss is associated with a rise in plasma calcium levels, and many studies have suggested that calcium loss via urinary excretion may predispose patients to osteoporosis [8, 9] . Although the infl uence of ovariectomy on urinary calcium excretion has been extensively studied [10, 11] , the combined infl uence of estrogen defi ciency and low-calcium diet have not been well examined. Therefore, we were interested in investigating the combined infl uence of estrogen defi ciency and low dietary calcium on bone loss and urinary calcium excretion, given the assumption that postmenopausal women tend to have a fairly low calcium intake [12, 13] and are in negative calcium balance [11, 14] .
Many epidemiological studies have reported that the severity of arterial diseases such as arterial calcifi cation and stiffness is inversely related to bone loss, i.e., osteoporosis [15] [16] [17] [18] . Although osteoporosis and arterial disease seem to be associated, the nature of this relationship is controversial. Women lose about 5% of their trabecular bone every year and about 15% of their total bone in the fi rst 5 years after menopause [19, 20] . The incidence of cardiovascular disease in women before menopause is signifi cantly lower than in males [21] . However, within a few years after meno-pause, the incidence of cardiovascular disease in women equals that of males in the same age range [22, 23] . Estrogen replacement therapies reduce the risk of rapid bone loss [24] and arterial disease [25] in postmenopausal women. Therefore, estrogen defi ciency seems to relate to the parallel progression of bone loss and aortic disease.
Although benefi ts of long-term estrogen therapy for agerelated decreases in systemic arterial compliance have been described in postmenopausal women [26, 27] , the effects of estrogen on arterial stiffness are now contradictory [26] [27] [28] . Elastin degeneration and calcium deposition increase arterial stiffness [29] and induce the migration of vascular smooth muscle cells into the endothelium [30] , which is considered to be a risk factor for atherosclerosis [31] . Estrogen has been reported to inhibit the proliferation of vascular smooth muscle cells [32] and may also exert a Ca 2+ channel blocker-like effect, suggesting that estrogen treatment could inhibit progression of arterial calcifi cation [33] . However, it is unclear whether rapidly induced estrogen defi ciency affects aortic degeneration and elastin calcium deposition. In the present study, we postulated that increased elastin calcium content and rapid degenerative changes in ovariectomized rats might induce an increase in aortic stiffness.
The purposes of this study were (1) to investigate how estrogen defi ciency and/or low-calcium diet affects bone loss and urinary calcium excretion; (2) to assess the alteration of elastin components and arterial stiffness induced by estrogen defi ciency; and (3) to determine whether the degree of bone loss resulting from estrogen defi ciency and low-calcium diet is related to the extent of arterial degeneration, elastin calcium deposition, and aortic stiffening.
Materials and methods

Experimental animals and feeding protocol
Twenty-eight female Sprague-Dawley rats, 6 weeks old, were randomized into four groups: the OVX-Low calcium (0.1% dietary Ca, 0.6% dietary P) group (OL, n = 6) and OVX-Normal calcium (0.6% dietary Ca, 0.6% dietary P) group (ON, n = 6) were ovariectomized via the dorsal route, and the Sham-Low calcium group (SL, n = 8) and the ShamNormal calcium group (SN, n = 8) were operated on without the ovaries being removed. The experimental period was 12 weeks. The rats were kept in individual cages (15 × 25 × 19.5 cm) and allowed access to food and distilled water ad libitum. Food consumption and body weight gain were measured every second day. Room temperature was kept at 24° ± 1°C and humidity at 50% ± 5%. Fluorescent lights were on from 8:00 A.M. to 8:00 A.M. Animal care and experimental procedure were approved by the Animal Experimental Committee of the University of Tsukuba.
Serum calcium, phosphorus, bone turnover markers, and 1,25-(OH) 2 D 3 At the end of the experimental period, all the rats were deprived of food overnight. Under ether anesthesia, animals were killed by exsanguinations from the abdominal aorta. The blood samples were centrifuged at 2500 rpm for 15 min to extract the serum. The level of serum Ca was measured by inductively coupled plasma atomic emission spectroscopy (ICAP-AES; 575 V, Nippon Jarrell-Ash), and phosphorus was determined by the Fiske-Subarrow method [34] . Bone-type alkaline phosphatase (BAP) and tartrateresistant acid phosphatase (TRAP) activities were measured as previously reported [35] . Serum 1,25-(OH) 2 D 3 was detected using a 1,25-(OH) 2 D 3 Radio Immunoassay (RIA) kit (Immunodiagnostic Systems, Fountain Hills, AZ, USA).
Measurement of bone mineral density
The lumbar spine and left and right tibiae of each rat were isolated by dissection, and freed from any muscle and connective tissue. Thereafter, bone mineral density (BMD) values for the L3-L6 lumbar spine and the whole tibiae were measured by dual-energy X-ray absorptiometry (DXA; Aloka DCS-600R). Analysis of tibial BMD was carried out as previously reported [36] . Briefl y, the proximal one-fi fth of the tibia, including the epimetaphyseal region representing the trabecular sites, and middle one-fi fth of the tibia representing the cortical diaphyseal region, were used.
Femoral weights and mechanical breaking test
At each dissection, femur samples were collected and freed from adhering connective tissues. Thereafter, the bone strength at the middle diaphysis of the femur was tested by measuring the mechanical strength, with an Iio DYN-1255 instrument as previously reported [37] . The force necessary to produce a break at the center of the femur was measured under the following conditions: the sample space was 1.0 cm, the plunger speed was 100.0 mm/min, the load range was 50.0 kg, and the chart speed was 120.0 cm/min. Afterward, the femurs were dried at 95°C for 24 h to measure their dry weight. The bones were dry-ashed at temperatures from 150° to 550°C, with 50°C increments at each 4 h and at 600°C for 24 h, and then the ash weight was measured.
Calcium and deoxypyridinoline excretions in urine Animals were placed in individual metabolic cages (24 × 20 × 18 cm 3 ). The fi rst phase was carried out on the 3rd and 4th day after starting the experimental diet period (phase I). The next phase (phase II) was carried out on the 31st and 32nd days. The third phase (phase III) was on the 56th and 57th days. The fi nal phase (phase IV) took place on the 80th and 81st days, just before the end of the experimental diets period. At each phase, urine was collected over two 24-h periods. Urine was collected under acidic conditions using 2 ml 2 N hydrochloric acid. All urine was centrifuged at 2500 rpm for 15 min to eliminate refuse. The urinary Ca was measured using the same method as that for the biochemical assay of the serum. The bone resorption marker deoxypyridinoline (Dpd, bone-specifi c type 1 collagen degradation product) was measured in 24-h urine samples from all four collection phases, using commercially available kits (Metra Dpd EIA Kit, Quidel, San Diego, CA, USA).
Aortic biochemical studies
The descending thoracic aorta was divided longitudinally into two parts. Each sample was dried, and its dry weight was determined. One-half of the aorta from each rat was designated for the measurement of the content of aortic calcium. The other half of the aorta was boiled with 0.1 N NaOH for 50 min, according to the method of Lansing et al., for the determinations of elastin content (alkali-resistant elastin preparation) [38] , and calcium content in elastin. The elastin content and calcium content in elastin were also determined from the aortic arches. The calcium content was measured using the same method as that for the biochemical assay of the serum.
Aortic biomechanical studies
To obtain a static stress-strain curve, each ring specimen of thoracic aorta was mounted as an intact loop between two smooth rods attached to an Instron-type tensile testing machine (Toyo Baldwin, Tokyo, Japan) as previously described [39, 40] . Briefl y, 2-mm ring specimens for tensile testing were excised from the proximal portion of each descending thoracic aorta, and were immersed in saline solution at 4°C. The incremental elastic modulus (a measure of arterial stiffness) of the aorta at an extension ratio of 1.5 was defi ned as the ratio of the incremental stress to the incremental strain of 0.1 across the extension ratio of 1.5, which is comparable to the aortic wall distension at an arterial blood pressure of 100 mmHg. The ultimate tensile stress (tensile strength) and ultimate tensile strain were obtained from the stress-strain curves as the values at the breaking point of the specimen.
Statistical analysis
All the data are expressed as the mean ± SE. One-way and two-way analysis of variance (ANOVA) were used to test for statistically signifi cant differences between groups. Analysis of effects of ovariectomy, dietary calcium, and interaction between those factors as grouping variables was performed, and the signifi cance between individual groups was determined using a post hoc protected least squares difference (PLSD) test. Statistical comparisons of calcium and Dpd excretions in urine among four groups over time were performed by a mixed design two-way ANOVA with repeated measures. After signifi cant interactions, one-way ANOVA were employed each phase (four phases) to compare and contrast the effect of groups. If a signifi cant difference was detected, these were further evaluated by post hoc PLSD test. Association between bone turnover markers and urinary calcium excretion was performed by Pearson correlation test. A signifi cant level of P < 0.05 was used for all comparisons. All statistical treatments were done using the Stat View 5.01 software (SAS Institute, Cary, NC, USA, 2000-2001).
Results
Body weight, food intake, and food effi ciency Table 1 shows body weight, food intake, and food effi ciency. Initial body weight did not differ among the four groups. Two-way ANOVA analysis showed that ovariectomy significantly altered the fi nal body weight, body weight gain, food intake, and food effi ciency (P < 0.0001), but dietary calcium did not signifi cantly infl uence these in both Sham-operated groups and OVX groups.
BMD of lumbar spine and tibia BMD of the lumbar spine and tibia are shown in Fig 1. BMD of the lumbar spine, which contains a cancellous-rich region, was signifi cantly lower in OL than in ON and Shamoperated groups (SN and SL). BMD of the tibial proximal metaphysis, which also contains a cancellous-rich region, showed the same trend as the lumbar spine. Both ovariectomy (P < 0.0001) and dietary calcium (P < 0.0001) had signifi cant effects on the cancellous BMD of the lumbar spine and tibial proximal metaphysis, and the interaction was highly signifi cant for the BMD of the tibial proximal metaphysis (P = 0.0479). The low-calcium diet signifi cantly reduced the BMD of the tibial diaphysis, which contains little or no cancellous bone (cortical-abundant region), in both Sham-operated groups and OVX groups (P < 0.001), but estrogen defi ciency alone did not reduce the BMD values.
Serum calcium, phosphorus, bone turnover markers, and serum PTH and 1,25 (OH) 2 D 3 levels Table 2 shows serum calcium, phosphorus, BAP, and TRAP levels. No signifi cant differences in serum calcium and phosphorus were observed among the groups. Two-way ANOVA analysis showed that the interaction between ovariectomy and dietary calcium was signifi cant for serum calcium (P = 0.0017), but the values were physiologically within normal range. The combined infl uence of estrogen defi ciency and low-calcium diet (OL) produced signifi cant increases in BAP levels compared with the other groups and also showed signifi cant increases in TRAP levels compared with SL. BAP and TRAP levels in OVX groups (ON and OL) were correlated with urinary calcium excretion at 12 weeks from OVX operation (Pearson r = 0.565, P < 0.05 for BAP and Pearson r = 0.592, P < 0.05 for TRAP), but in sham groups (SN and SL) those correlations were not observed. The lowcalcium diet signifi cantly increased serum 1,25 (OH) 2 D 3 level in both Sham-operated groups (P < 0.001) and OVX groups (P < 0.01). The serum 1,25 (OH) 2 D 3 level was significantly higher in ON than in SN. Two-way ANOVA analysis showed that ovariectomy tended to alter the serum 1,25 (OH) 2 D 3 level (P = 0.0643), but dietary calcium signifi cantly infl uenced the level (P < 0.001).
Femoral characteristics and biomechanical testing
Femoral dry and ash weights were signifi cantly lower in OL than in the other groups (Table 3) . Ovariectomy (P < 0.0001) and dietary calcium (P < 0.0001) had signifi cant effects on the dry and ash weights. The femoral breaking force was reduced by low-calcium diet in both Sham-operated groups and OVX groups, and the femoral breaking energy was signifi cantly lower in OL than in the other groups. 
Calcium and Dpd excretions in urine
Calcium and Dpd excretions in urine are shown in Fig. 2 . Two-way ANOVA with repeated measures for calcium and Dpd excretion in urine showed signifi cant group-by-time interactions (P < 0.0001) as well as group (P < 0.0001) and time (P < 0.0001) effects. Urinary Ca excretion in normal calcium diet groups (SN and ON) were signifi cantly higher than in SL from phase I to phase IV and in OL from phase I to phase II. With time, the urinary Ca excretion in OL increased and was signifi cantly higher than in SL from phase III to phase IV. Urinary Ca excretion was signifi cantly higher in ON than in SN only in phase III. Urinary Dpd excretion did not differ among the groups at phase I, but from phase II to phase IV, it was signifi cantly higher in SL and OVX groups (OL and ON) than in SN. Especially, in phase II, urinary Dpd excretion was signifi cantly in OL higher than in SN and SL. Urinary Dpd excretion in SL and OVX groups (OL and ON) began with the increase being greatest in an earlier period (phase II), and it declined with time.
Aortic biochemical results
Calcium content in the thoracic aorta did not differ among the four groups (Table 4 ). The content of elastin in the thoracic and arch aortas did not differ among the four groups, and there was also no signifi cant difference in the elastin calcium content.
Aortic biomechanical results
There were no signifi cant differences in incremental elastic modulus, ultimate tensile stress, and ultimate tensile extension ratio among the four groups (Table 5 ).
Discussion
We observed that the combined infl uence of estrogen deficiency and low-calcium diet decreased the BMD of both tibia and lumbar spine. Additionally, the combination of estrogen defi ciency and low-calcium diet resulted in significantly increased urinary calcium excretion and bone turn- Calcium and deoxypyridinoline excretion in urine. Four balances were carried out to determine the 24-h total calcium and deoxypyridinoline excretions in urine. Urine was collected at four phases: I, the 3rd and 4th days; II, the 31st and 32nd days; III, the 56th and 57th days; and IV, the 80th and 81st days from the day of ovariectomy and the start of experimental diet (Low and Normal calcium diets). Data show means ± SE. SL, Sham-operated Low calcium group; SN, Sham-operated Normal calcium group; OL, Ovariectomy Low calcium group; ON, Ovariectomy Normal calcium group *P < 0.05, **P < 0.01, ***P < 0.001 vs. SN, # P < 0.05, ## P < 0.01 vs. SL over marker expression at 12 weeks after ovariectomy. However, estrogen defi ciency and/or low-calcium diet did not affect aortic stiffness or elastin degeneration and calcium deposition during periods of rapid change in bone metabolism. The BMD in both cortical (tibial diaphysis) and cancellous (tibial proximal metaphysis and lumbar spine) bones was signifi cantly decreased in OVX rats fed a low-calcium diet (Fig. 1) . These results correspond to the reduced dry and ash femur weights observed in OVX rats fed a lowcalcium diet (see Table 3 ). Femoral breaking force and energy were also markedly decreased in OVX rats fed low calcium diet (Table 3) , suggesting the increased risk of fracture. Previous studies using OVX rats fed 0.1% low-calcium diet have shown decreases in BMD as well as increases in circulating parathyroid hormone and 1,25-(OH) 2 D 3 [7, 41] . Consistent with the results of previous studies, the present study showed that serum 1,25-(OH) 2 D 3 in OVX rats fed a low-calcium diet clearly increased, but the normal calcium diet suppressed the level.
At 4 weeks after ovariectomy, urinary Dpd excretion in OVX rats fed a low-calcium diet was signifi cantly higher than in sham-operated rats fed low-calcium diet (Fig. 2) . The increased Dpd excretion is suggestive of osteopenia resulting from increased bone resorption [42] . In this study, it is possible that increased bone resorption in OVX rats fed low-calcium diet led to higher bone loss at the earlier time point of 4 weeks after ovariectomy. Despite the increase in bone resorption, urinary calcium excretion was unchanged at 4 weeks (Fig. 2) . Estrogen receptors modulate tubular calcium reabsorption in the kidneys [43] , and urinary calcium excretion signifi cantly increases after menopause, indicating that renal tubular reabsorption of calcium decreases in the estrogen defi ciency state [44] . It has been generally considered that higher urine calcium excretion after menopause refl ects an increase in the fi ltered load of calcium from the kidney, occurring as a result of increased bone resorption [45] . However, in the present study, it is possible that in 4 weeks after ovariectomy, calcium reabsorption in the kidneys might still occur through an alternate mechanism.
Urinary calcium excretion in OVX rats fed a low-calcium diet started to increase 8 weeks after ovariectomy and was signifi cantly higher than that of sham-operated rats fed a low-calcium diet from 8 weeks to 12 weeks after ovariectomy (see Fig. 2 ). At 12 weeks after ovariectomy, positive correlations between urinary calcium excretion and the expression of two bone turnover markers, BAP and TRAP, were observed in the OVX groups only. Morris et al. also showed that OVX rats with higher bone turnover lost more urinary calcium when compared to those with lower levels of bone turnover [46] . The positive correlation between urinary calcium excretion and expression of bone turnover markers in the present study was not observed in shamoperated rats regardless of dietary calcium intake at all time points, suggesting that estrogen might infl uence the renal reabsorption of calcium [43] . Estrogen receptors are present in human bone [47] , and increases in urinary calcium excretion during estrogen defi ciency are accompanied by increased bone resorption [46] . Therefore, at 12 weeks after ovariectomy, the increased urinary calcium excretion in OVX rats fed low-calcium diet may refl ect not only increased bone resorption but also an inhibitory effect on renal tubular calcium reabsorption. In the present study, although the bone formation marker, serum BAP, in OVX rats fed lowcalcium diet was signifi cantly higher than in the other groups, the bone resorption marker, serum TRAP, was not so much higher. This fi nding might be because the bone turnover markers were analyzed using a serum sample at the endpoint of this experiment (i.e., 12 weeks after ovariectomy) when much progression of bone loss had already occurred compared with the rapid progression of bone loss at the earlier time point (i.e., 4 weeks after ovariectomy). Actually, at 4 weeks after ovariectomy, urinary Dpd excretion in OVX rats fed a low-calcium diet was signifi cantly higher than that in both sham-operated rats fed a lowcalcium diet and sham-operated rats fed a normal calcium diet. Taken together, our results suggest that increased urinary calcium and bone turnover might be risk factors for osteoporosis in postmenopausal women who have low calcium intake.
In the present study, urinary calcium excretion was signifi cantly higher in OVX rats fed normal calcium diet at 8 weeks after ovariectomy when compared to sham-operated rats, whereas no difference was observed at 12 weeks (Fig.  2) . The effect of ovariectomy on urine calcium excretion is currently controversial, with reports of no effect [7, 48] and also of an increased excretion [10, 11] . However, the previous studies only assessed urinary calcium excretion only at one time point. Therefore, the confl icting fi ndings may have been caused by differences in the age of the rats or the duration of the experiments.
In the present study, we did not observe any changes in aortic stiffness or elastin degeneration and calcium deposition during estrogen defi ciency (see Tables 4, 5 ). Potential protective mechanisms of estrogen relating to arterial stiffness include induction of endothelium-dependent vasodilative factors [49, 50] and inhibition of vasocontracting factors [51, 52] (i.e., functional factors). In the present study, to analyze arterial stiffness we used dissected thoracic aorta, which did not have dynamic functional factors and might be infl uenced by structural factors such as the composition of arterial wall elastin and its calcium content. A previous study showed that the calcifi cation level of the arterial tunica media was positively correlated with antemortem aortic pulse wave velocity [53] . In the present study, estrogen deficiency did not induce aortic elastin degeneration or calcifi cation, which may have in turn caused the observed lack of change in aortic stiffness. We cannot rule out the possibility of the estrogen defi ciency-induced increase of arterial stiffness in aged OVX rats, as it is expected that signifi cant changes in phenotypes of artery relating to arterial stiffness can be observed. However, to our knowledge, little has been reported whether aged OVX rats induce increase in arterial stiffness. Furthermore, structural arterial alterations have been observed to develop within 2 months in a rat hypertension model [54] , but there were no changes in the osteoporotic model of the young rat in the present study. Therefore, future studies using a combination model rat, e.g., atherosclerotic stimuli in ovariectomized rats or aged ovariectomized rats, may help to clarify the epidemiological links between osteoporosis and aortic diseases.
We also did not observe any changes in aortic stiffness or elastin degeneration and calcium deposition when estrogen defi ciency was combined with low-calcium diet (Tables  4, 5 ). The paradox of bone loss accompanied by aortic calcifi cation, where there might be a calcium shift from bone to arteries (calcium shift theory), has been reported in previous epidemiological studies. However, in the present study, aortic calcifi cation and stiffness were unchanged during periods of rapid bone loss caused by either estrogen defi ciency or the combined infl uence of estrogen defi ciency and low-calcium diet. It is possible that the surrounding vascular tissue was insuffi cient to accept plasma calcium deposition after bone resorption.
In conclusion, we observed that the combined infl uence of estrogen defi ciency and low-calcium diet decreased the bone mineral density of both cortical and cancellous bones in the tibia and lumbar spine. The combination of estrogen defi ciency and low-calcium diet also caused an increase in urinary calcium corresponding to increased bone turnover 12 weeks after ovariectomy. Although rapid changes were observed in bone metabolism, neither estrogen defi ciency nor low-calcium diet affected aortic stiffness or elastin degradation and calcium deposition. These data suggest that rapid bone loss and biochemical aortic alterations caused by estrogen defi ciency and low-calcium diet did not progress simultaneously.
